Abstract
Background: Low bone mineral density (BMD) has been reported in HIV-infected women and men. Methods: We analysed cross-sectional BMD measured by regional dual X-ray absorptiometry at the lumbar spine (LS) and femoral neck (FN) in 152 HIV-negative and 274 HIV-positive (HIV+) women, adjusted for traditional low BMD risk factors. Results: BMD was significantly lower in protease inhibitor (Pl) users than in all other groups, and highest in HIV-negative women. In multivariate analyses the prevalence of T-score
Cite
CITATION STYLE
Anastos, K., Lu, D., Shi, Q., Mulligan, K., Tien, P. C., Freeman, R., … Hessol, N. A. (2007). The association of bone mineral density with HIV infection and antiretroviral treatment in women. Antiviral Therapy, 12(7), 1049–1058. https://doi.org/10.1177/135965350701200701
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.